版本:
中国

BRIEF-Prometic Life Sciences Inc plasminogen administration shown to reduce acute lung injury

May 8 Prometic Life Sciences Inc:

* Prometic Life Sciences Inc - plasminogen administration shown to reduce acute lung injury ("ali") in an acute pancreatitis model

* Prometic Life Sciences Inc - PBI-4050 is safe and well tolerated and shows evidence of benefit in idiopathic pulmonary fibrosis Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐